Radiological assessment of response to neoadjuvant transcatheter hepatic therapy with irinotecan-eluting beads (DEBIRI(®)) for colorectal liver metastases does not predict tumour destruction or long-term outcome. (Q46134242)
Jump to navigation
Jump to search
scientific article published on 6 August 2013
Language | Label | Description | Also known as |
---|---|---|---|
English | Radiological assessment of response to neoadjuvant transcatheter hepatic therapy with irinotecan-eluting beads (DEBIRI(®)) for colorectal liver metastases does not predict tumour destruction or long-term outcome. |
scientific article published on 6 August 2013 |
Statements
Radiological assessment of response to neoadjuvant transcatheter hepatic therapy with irinotecan-eluting beads (DEBIRI(®)) for colorectal liver metastases does not predict tumour destruction or long-term outcome (English)
D F J Dunne
E O'Grady
A Smethurst
M Terlizzo
H Z Malik
S W Fenwick